JP2020536085A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020536085A5 JP2020536085A5 JP2020518682A JP2020518682A JP2020536085A5 JP 2020536085 A5 JP2020536085 A5 JP 2020536085A5 JP 2020518682 A JP2020518682 A JP 2020518682A JP 2020518682 A JP2020518682 A JP 2020518682A JP 2020536085 A5 JP2020536085 A5 JP 2020536085A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- combination according
- tuberculosis
- medicament
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 201000008827 tuberculosis Diseases 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762568430P | 2017-10-05 | 2017-10-05 | |
| US62/568,430 | 2017-10-05 | ||
| US201862716054P | 2018-08-08 | 2018-08-08 | |
| US62/716,054 | 2018-08-08 | ||
| PCT/EP2018/077222 WO2019068910A1 (en) | 2017-10-05 | 2018-10-05 | THIAZOLINO 2-PYRIDONES WITH A FUSED CYCLE IN COMBINATION WITH A MEDICINE AGAINST TUBERCULOSIS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020536085A JP2020536085A (ja) | 2020-12-10 |
| JP2020536085A5 true JP2020536085A5 (2) | 2021-11-11 |
| JP7233059B2 JP7233059B2 (ja) | 2023-03-06 |
Family
ID=63840820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020518682A Active JP7233059B2 (ja) | 2017-10-05 | 2018-10-05 | 結核に対する薬剤と組み合わせた環融合型チアゾリノ２－ピリドン |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11129816B2 (2) |
| EP (1) | EP3691619A1 (2) |
| JP (1) | JP7233059B2 (2) |
| KR (1) | KR20200066315A (2) |
| CN (1) | CN111246848A (2) |
| PH (1) | PH12020550567A1 (2) |
| WO (1) | WO2019068910A1 (2) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3638681A1 (en) * | 2017-06-13 | 2020-04-22 | Quretech Bio AB | Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria |
| WO2021018387A1 (en) | 2019-07-30 | 2021-02-04 | Qurient Co., Ltd. | Different forms of 6-chloro-2-ethyl-n-(4-(4-(4-(trifluoromethoxy)phenyl)piperidine-1-yl)benzyl)imidazo[1,2-a]pyridine-3-carboxamide |
| WO2021224501A1 (en) | 2020-05-08 | 2021-11-11 | Quretech Bio Ab | Ring-fused 2-pyridone compounds, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria |
| CN112921107A (zh) * | 2020-12-31 | 2021-06-08 | 深圳市慢性病防治中心(深圳市皮肤病防治研究所、深圳市肺部疾病防治研究所) | 结核分枝杆菌异质性耐药检测方法、试剂盒及应用 |
| CN113045494B (zh) * | 2021-03-29 | 2022-04-26 | 四川大学华西医院 | 吡啶酮衍生物及其在制备预防和/或治疗结核分枝杆菌所引起的结核病的药物中的用途 |
| CN115531388B (zh) * | 2022-11-04 | 2024-03-22 | 首都医科大学附属北京胸科医院 | 治疗结核病的药物组合物 |
| CN118593520B (zh) * | 2024-05-23 | 2025-01-24 | 蚌埠医科大学 | 化合物k67在制备抗结核药物中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG184073A1 (en) | 2010-03-18 | 2012-10-30 | Pasteur Institut Korea | Anti-infective compounds |
| KR20140093610A (ko) | 2011-04-21 | 2014-07-28 | 재단법인 한국파스퇴르연구소 | 소염 화합물 |
| US10425481B2 (en) | 2013-05-13 | 2019-09-24 | Telefonaktiebolaget Lm Ericsson (Publ) | Node in a telecommunications network, a virtual network element and methods for retrieving resource identification information |
| WO2014185853A1 (en) * | 2013-05-14 | 2014-11-20 | Quretech Bio Ab | Compounds and methods for treatment of chlamydia infections |
| US9814711B2 (en) * | 2013-07-26 | 2017-11-14 | Sanofi | Antitubercular composition comprising rifampicin, isoniazid, ethambutol and pyrazinamide and its process of preparation |
| JP2016525562A (ja) * | 2013-08-02 | 2016-08-25 | インスティチュート パスツール コリア | 抗感染症化合物 |
| CN107074878B (zh) | 2014-11-13 | 2019-12-24 | 快尔生物技术公司 | 2,3-二氢-噻唑并[3,2-a]吡啶-5-酮衍生物、其中间体及其作为抗细菌剂的用途 |
| EP3439655B1 (en) * | 2016-04-08 | 2021-03-03 | Quretech Bio AB | Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of tuberculosis |
-
2018
- 2018-10-05 CN CN201880067818.1A patent/CN111246848A/zh active Pending
- 2018-10-05 EP EP18785905.3A patent/EP3691619A1/en not_active Withdrawn
- 2018-10-05 JP JP2020518682A patent/JP7233059B2/ja active Active
- 2018-10-05 US US16/652,829 patent/US11129816B2/en not_active Expired - Fee Related
- 2018-10-05 WO PCT/EP2018/077222 patent/WO2019068910A1/en not_active Ceased
- 2018-10-05 KR KR1020207010849A patent/KR20200066315A/ko active Pending
-
2020
- 2020-05-05 PH PH12020550567A patent/PH12020550567A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020536085A5 (2) | ||
| EP4596041A3 (en) | Farnesoid x receptor agonists and uses thereof | |
| CA2956871C (en) | Compounds active towards bromodomains | |
| JP2015057451A5 (2) | ||
| WO2015165413A8 (zh) | 一种新型的稳定型抗体药物耦联物及其制备方法和用途 | |
| JP2017537928A5 (2) | ||
| HUE055873T2 (hu) | Arany klaszter (AuCs) vagy AuCs-t tartalmazó anyagok alkalmazása glaukóma megelõzésére és/vagy kezelésére szolgáló gyógyszer elõállítására | |
| WO2018004283A3 (ko) | 글루카곤 유도체, 이의 결합체, 및 이를 포함하는 조성물, 및 이의 치료적 용도 | |
| WO2015077503A8 (en) | Autotaxin inhibitor compounds | |
| WO2016149501A3 (en) | Modified therapeutic agents and compositions thereof | |
| JP2016147915A5 (2) | ||
| JP2018202656A5 (2) | ||
| WO2015066302A3 (en) | Compositions, methods of use, and methods of treatment | |
| EP4324824A3 (en) | Combination antibacterial composition and short-course antibacterial regimen | |
| CN110035744A (zh) | 一种尼拉帕尼缓控释药物组合物及其用途 | |
| IL276952A (en) | History of 4,2-diaminoquinazolines and their medicinal uses | |
| EP3318282A4 (en) | AGGREGATE COMPOSITION CARRIER AND COMPOSITION THEREOF | |
| CY1123844T1 (el) | Φαρμακευτικες συνθεσεις και χρησεις που απευθυνονται σε διαταραχες λυσοσωμιακης αποθηκευσης | |
| CA3010568A1 (en) | Oromucosal nanofiber carriers for therapeutic treatment | |
| WO2016191458A3 (en) | Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment | |
| JP2016540030A5 (2) | ||
| HUE057216T2 (hu) | Genotípus-rétegzés cukorbetegség kezelésében és megelõzésében | |
| CA3010981A1 (en) | Therapeutic nanoparticles for the treatment of neuroblastoma and other cancers | |
| HUE055732T2 (hu) | Új tetrazolvegyületek és felhasználásuk a tuberkulózis kezelésében | |
| JP2017197541A5 (2) |